BiBBInstruments Yönetim

Yönetim kriter kontrolleri 2/4

BiBBInstruments CEO'su Fredrik Lindblad, Aug2016 tarihinde atandı, in görev süresi 8.17 yıldır. şirketin hisselerinin 1.65% doğrudan sahiptir ve bu hisselerin değeri SEK 2.35M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.5 yıl ve 9.2 yıldır.

Anahtar bilgiler

Fredrik Lindblad

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	8.2yrs
CEO sahipliği	1.6%
Yönetim ortalama görev süresi	6.5yrs
Yönetim Kurulu ortalama görev süresi	9.2yrs

Son yönetim güncellemeleri

Recent updates

Is BiBBInstruments (NGM:BIBB) In A Good Position To Deliver On Growth Plans?

Dec 18

We're Keeping An Eye On BiBBInstruments' (NGM:BIBB) Cash Burn Rate

Dec 16

CEO

Fredrik Lindblad (57 yo)

8.2yrs

Görev süresi

Mr. Fredrik Lindblad, M.B.A., MSc ME, B.Sc BA, Civ. Ing., Civ. ek. has been Chief Executive Officer at BiBBInstruments AB (publ) since August 2016.Mr. Lindblad serves as Chief Executive Officer of Tjörröd...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fredrik Lindblad	Chief Executive Officer	8.2yrs	Veri yok	1.65% SEK 2.4m
Charles Walther	Founder	11.8yrs	Veri yok	11.95% SEK 17.1m
Esther Brannstrom	Chief Technology Officer	4.5yrs	Veri yok	Veri yok
Stephan Dymling	Senior Technology Adviser & Director	4.8yrs	Veri yok	1.05% SEK 1.5m

6.5yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: BIBB 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Charles Walther	Founder	11.6yrs	Veri yok	11.95% SEK 17.1m
Stephan Dymling	Senior Technology Adviser & Director	11.1yrs	Veri yok	1.05% SEK 1.5m
Erik von Schenck	Chairman of the Board	7.3yrs	Veri yok	Veri yok
Sara Lindroth	Independent Director	5.9yrs	Veri yok	0.14% SEK 197.2k

9.2yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BIBB 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.2 yıldır).

BiBBInstruments Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Independent Director recently bought kr58k worth of stock

Chief Executive Officer recently bought kr101k worth of stock

Chief Executive Officer recently bought kr102k worth of stock

Chief Executive Officer recently bought kr55k worth of stock

Chief Executive Officer recently bought kr60k worth of stock

Less than half of directors are independent

Recent updates

BiBBInstruments AB to Report Q4, 2024 Results on Nov 08, 2024

BiBBInstruments AB Announces New Peer-Reviewed Clinical Case Series in the U.S. Shows 100% Diagnostic Accuracy with Endodrill Gi

BiBBInstruments AB Announces Successful Introduction of EndoDrill GI at University Hospital Center Sestre Milosrdnice in Zagreb, Croatia

BiBBInstruments AB to Report Q2, 2024 Results on Aug 21, 2024

BiBBInstruments AB Announces Successful Case Studies with EndoDrill GI Continue in Norway and Sweden

BiBBInstruments AB Announces Successful Clinical Pilot Study with EndoDrill GI Published in Peer Reviewed Scientific Journal

Bibbinstruments AB First Clinical Tissue Acquisition Procedures with Endodrill® Gi At Karolinska University Hospital in Stockholm Have Been Successfully Performed

BiBBInstruments AB to Report Q1, 2024 Results on May 03, 2024

Independent Director recently bought kr58k worth of stock

New major risk - Financial position

Chief Executive Officer recently bought kr101k worth of stock

Bibbinstruments AB Announces First US Clinical Cases Successfully Conducted with Endodrill GI

BiBBInstruments AB to Report Fiscal Year 2023 Results on Feb 09, 2024

BiBBInstruments AB to Report Nine Months, 2023 Results on Nov 10, 2023

Bibb Receives Approval of Two Patents in Europe for Endodrill

BiBBInstruments AB to Report Q2, 2023 Results on Aug 25, 2023

New major risk - Financial position

Chief Executive Officer recently bought kr102k worth of stock

New minor risk - Shareholder dilution

BiBBInstruments AB Reports Positive Results from Clinical Pilot Study with EndoDrill URO

Chief Executive Officer recently bought kr55k worth of stock

Chief Executive Officer recently bought kr60k worth of stock

BiBBInstruments AB to Report Fiscal Year 2022 Results on Feb 10, 2023

Less than half of directors are independent

BiBBInstruments AB to Report Q3, 2022 Results on Nov 11, 2022

BiBBInstruments AB to Report Q2, 2022 Results on Aug 26, 2022

Chairman of the Board recently bought kr64k worth of stock

BiBBInstruments AB, Annual General Meeting, Jun 14, 2022

BiBBInstruments Develops the CE-Marked Electromechanical Biopsy Instruments for Endoscopic Use

Less than half of directors are independent

BiBBInstruments AB to Report Q1, 2022 Results on May 06, 2022

Founder recently bought kr69k worth of stock

Is BiBBInstruments (NGM:BIBB) In A Good Position To Deliver On Growth Plans?

BiBBInsumentsts Cancer Study Comes to Early End After Convincing Data

Chairman of the Board recently bought kr73k worth of stock

BiBBinstruments AB Initiates Clinical Trial in Bladder Cancer

New 90-day high: kr9.50

We're Keeping An Eye On BiBBInstruments' (NGM:BIBB) Cash Burn Rate

New 90-day high: kr8.12

New 90-day high: kr6.14

BiBBInstruments AB to Report Q3, 2020 Results on Nov 13, 2020

New 90-day low: kr4.16

BiBBInstruments AB to Report Q2, 2020 Results on Aug 28, 2020

New 90-day high - kr5.20

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş